Close

Axim International, Inc. (AXIM) Secures U.S. Patent Allowance for Suppository Formulations Comprised of Cannabinoids

October 23, 2018 9:13 AM EDT Send to a Friend
AXIM® Biotechnologies, Inc. (AXIM) today announced that the United States Patent and Trademark Office (USPTO) has issued a patent (US ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login